Efficacy of CRISPR-Cas9 Gene Editing Versus Latency Reversing Agents for HIV Proviral Elimination in ART Suppressed Patients: A Review
2025 | IDOSR JOURNAL OF APPLIED SCIENCES | Pp. 77-81
Despite sustained viral suppression achieved through antiretroviral therapy (ART), HIV persists in latently infected cells, forming proviral reservoirs that remain the principal barrier to cure. Latency reversing agents (LRAs) and CRISPR-Cas9 gene editing are...